Eledon Pharmaceuticals (ELDN) Other Non-Current Liabilities (2015 - 2026)
Eledon Pharmaceuticals posted quarterly Other Non-Current Liabilities of $30.4 million for Q1 2026, down 12.72% year-on-year from $34.8 million in Q1 2025, and up 166.1% on a QoQ basis from $11.4 million in Q4 2025.
Eledon Pharmaceuticals (ELDN) has 6 years of Other Non-Current Liabilities data on file, last reported at $30.4 million in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Liabilities fell 12.72% year-over-year to $30.4 million; the trailing twelve-month figure through Mar 2026 stood at $30.4 million (down 12.72% YoY), and the FY2025 full-year result was $11.4 million, down 74.55% from the prior year.
- Other Non-Current Liabilities for Q1 2026 stood at $30.4 million, up from $11.4 million in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $120.8 million in Q2 2024 and bottomed at $11.4 million in Q4 2025.
- The 4-year median for Other Non-Current Liabilities is $39.8 million (2024), against an average of $49.0 million.
- The widest annual swing landed in 2024, when Other Non-Current Liabilities surged 115.06%; it then sank 81.37% in 2025.
- A 4-year view of Other Non-Current Liabilities shows it stood at $76.2 million in 2023, then plunged by 41.13% to $44.9 million in 2024, then plunged by 74.55% to $11.4 million in 2025, then soared by 166.1% to $30.4 million in 2026.
- The last three Other Non-Current Liabilities figures came in at $30.4 million (Q1 2026), $11.4 million (Q4 2025), and $21.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Eledon Pharmaceuticals | 419.90 Mn | 203.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30.38 Mn |
| Dec 31, 2025 | 11.42 Mn |
| Sep 30, 2025 | 21.95 Mn |
| Jun 30, 2025 | 22.51 Mn |
| Mar 31, 2025 | 34.81 Mn |
| Dec 31, 2024 | 44.87 Mn |
| Sep 30, 2024 | 23.96 Mn |
| Jun 30, 2024 | 120.82 Mn |
| Mar 31, 2024 | 89.55 Mn |
| Dec 31, 2023 | 76.21 Mn |
| Sep 30, 2023 | 55.74 Mn |
| Jun 30, 2023 | 56.18 Mn |
| Dec 31, 2016 | 3.45 Mn |
| Mar 31, 2016 | 126,000.00 |
| Dec 31, 2015 | 88,000.00 |
| Sep 30, 2015 | 51,000.00 |
| Jun 30, 2015 | 13,000.00 |